35 results
6-K
EX-10.2
CNTB
Connect Biopharma Holdings Ltd
12 Jun 24
Current report (foreign)
4:47pm
receive payments which may be “parachute payments.” Executive and the Company will each provide the 280G Firm access to and copies of any books, records
6-K
EX-10.3
CNTB
Connect Biopharma Holdings Ltd
12 Jun 24
Current report (foreign)
4:47pm
provide the 280G Firm access to and copies of any books, records, and documents as may be reasonably requested by the 280G Firm, and otherwise cooperate
6-K
EX-99.1
CNTB
Connect Biopharma Holdings Ltd
12 Dec 23
Connect Biopharma Announces Positive Rademikibart Global Phase 2b Topline Results in Adult Patients with Moderate-to-Severe Persistent Asthma
6:10am
-201-689-8560 (international) and use conference ID 13743026. To access the webcast presentation, please click here.
A replay of the webcast
6-K
EX-99.2
CNTB
Connect Biopharma Holdings Ltd
21 Nov 23
Exclusive License and Collaboration Agreement
6:13am
(international) and use conference ID 13742753. To access the webcast presentation, please click here.
A replay of the webcast and accompanying
6-K
EX-99.1
01ec4ad6ydeje
21 Nov 23
Exclusive License and Collaboration Agreement
6:13am
6-K
s8hfcl3he rexc0
12 Sep 23
Connect Biopharma Reports First Half 2023 Financial Results and Provides Business Update
4:47pm
6-K
k4gpmzdudxjr51tx
13 Sep 22
Connect Biopharma Reports First Half 2022 Financial Results
4:47pm
F-3/A
aaqaf7
17 Jun 22
Shelf registration (foreign) (amended)
5:19pm
F-3/A
puzde0ul6p0pw
20 May 22
Shelf registration (foreign) (amended)
6:54pm
F-3
EX-1.2
o948 gaaz36d1
15 Apr 22
Shelf registration (foreign)
5:27pm
F-3
d75mq0w3xyhn4u
15 Apr 22
Shelf registration (foreign)
5:27pm
20-F
EX-1.1
3e12xvhq
31 Mar 22
Annual report (foreign)
4:33pm
20-F
EX-4.13
vmon7o2 cvucz
31 Mar 22
Annual report (foreign)
4:33pm
20-F
kuwq 4gil2
31 Mar 22
Annual report (foreign)
4:33pm
6-K
EX-99.1
z4p7w 2i4
31 Aug 21
Index to the Unaudited Interim Condensed Consolidated Financial Statements
4:16pm
424B4
8pd0w8anojtu 1v24kg
19 Mar 21
Prospectus supplement with pricing info
4:49pm
F-1/A
nckbwe2u880kd
18 Mar 21
Registration statement (foreign) (amended)
6:15am
F-1/A
vmoduhdk wut5hqf
12 Mar 21
Registration statement (foreign) (amended)
5:02pm